Stock 000788 PKU HEALTHCARE CORP.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials PKU HealthCare Corp.,Ltd.

Equities

000788

CNE0000008M0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
5.65 CNY -1.40% Intraday chart for PKU HealthCare Corp.,Ltd. -3.75% -15.80%
04-26 Pku Healthcare Corp.,Ltd. Proposes Final Cash Dividend for the Year 2023 CI
04-25 PKU HealthCare Corp.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,111 3,969 3,659 4,083 4,434 3,999
Enterprise Value (EV) 1 2,720 3,614 3,438 3,990 4,058 3,624
P/E ratio 68.9 x 79.1 x 93.5 x 97.9 x 79.2 x 90.2 x
Yield 0.38% - - 0.34% - 0.39%
Capitalization / Revenue 1.34 x 1.58 x 1.85 x 1.83 x 2.13 x 1.82 x
EV / Revenue 1.17 x 1.44 x 1.74 x 1.78 x 1.95 x 1.65 x
EV / EBITDA 31.5 x 37.3 x 37.4 x 33 x 34.1 x 28.7 x
EV / FCF 23.3 x -67.2 x -22.7 x -60.7 x 10.7 x -45.2 x
FCF Yield 4.29% -1.49% -4.4% -1.65% 9.36% -2.21%
Price to Book 2.56 x 3.17 x 2.82 x 3.05 x 3.21 x 2.81 x
Nbr of stocks (in thousands) 595,987 595,987 595,987 595,987 595,987 595,987
Reference price 2 5.220 6.660 6.140 6.850 7.440 6.710
Announcement Date 15/04/19 28/05/20 20/04/21 28/04/22 27/04/23 25/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,316 2,509 1,977 2,237 2,077 2,194
EBITDA 1 86.41 96.86 91.87 121 119 126.4
EBIT 1 71.03 80.66 73.71 100.8 93.84 98.21
Operating Margin 3.07% 3.21% 3.73% 4.51% 4.52% 4.48%
Earnings before Tax (EBT) 1 65.21 65.9 52.58 61.91 70.59 74.29
Net income 1 45.18 50.19 39.18 43.14 55.98 44.36
Net margin 1.95% 2% 1.98% 1.93% 2.69% 2.02%
EPS 2 0.0758 0.0842 0.0657 0.0700 0.0939 0.0744
Free Cash Flow 1 116.7 -53.79 -151.1 -65.72 379.8 -80.09
FCF margin 5.04% -2.14% -7.64% -2.94% 18.28% -3.65%
FCF Conversion (EBITDA) 135% - - - 319.25% -
FCF Conversion (Net income) 258.22% - - - 678.36% -
Dividend per Share 2 0.0200 - - 0.0230 - 0.0260
Announcement Date 15/04/19 28/05/20 20/04/21 28/04/22 27/04/23 25/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 391 355 222 92.1 376 375
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 117 -53.8 -151 -65.7 380 -80.1
ROE (net income / shareholders' equity) 3.78% 4.06% 3.09% 3.29% 4.12% 3.17%
ROA (Net income/ Total Assets) 2.1% 2.19% 1.93% 2.6% 2.27% 2.42%
Assets 1 2,147 2,291 2,027 1,660 2,471 1,834
Book Value Per Share 2 2.040 2.100 2.180 2.250 2.320 2.390
Cash Flow per Share 2 0.8700 1.120 0.8000 0.7500 0.9500 0.7700
Capex 1 37.1 41.4 58.1 45.4 35.3 63.2
Capex / Sales 1.6% 1.65% 2.94% 2.03% 1.7% 2.88%
Announcement Date 15/04/19 28/05/20 20/04/21 28/04/22 27/04/23 25/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PKU HEALTHCARE CORP.,LTD. Stock PKU HealthCare Corp.,Ltd.
-15.80% 465M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.59% 727B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.89% 347B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.66% 319B
ABBVIE INC. Stock AbbVie Inc.
+0.24% 274B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.25% 238B
NOVARTIS AG Stock Novartis AG
+7.08% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-5.85% 203B
AMGEN INC. Stock Amgen Inc.
+4.23% 161B
PFIZER, INC. Stock Pfizer, Inc.
-1.70% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000788 Stock
  4. Financials PKU HealthCare Corp.,Ltd.